About this Journal Submit a Manuscript Table of Contents
Gastroenterology Research and Practice
Volume 2012 (2012), Article ID 506571, 5 pages
http://dx.doi.org/10.1155/2012/506571
Clinical Study

Preliminary Results of Hyperthermic Intraperitoneal Intraoperative Chemotherapy as an Adjuvant in Resectable Pancreatic Cancer

1Surgical Department, Didimotichon General Hospital, Didimotichon 68300, Greece
2Department of Clinical Oncology, Alexandroupolis General Hospital, Democritus University of Thrace, Greece
3Department of Anesthesiology, Didimotichon General Hospital, Greece
4Department of Radiology, Alexandroupolis General Hospital, Democritus University of Thrace, Greece

Received 25 February 2012; Accepted 26 March 2012

Academic Editor: Paul H. Sugarbaker

Copyright © 2012 Antonios-Apostolos K. Tentes et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. R. Bramhall, W. H. Allum, A. G. Jones, A. Allwood, C. Cummins, and J. P. Neoptolemos, “Treatment and survival in 13 560 patients with pancreatic cancer, and incidence of the disease, in the West Midlands: an epidemiological study,” British Journal of Surgery, vol. 82, no. 1, pp. 111–115, 1995. View at Publisher · View at Google Scholar · View at Scopus
  2. A. Jemal, A. Thomas, T. Murray, and M. Thun, “Cancer statistics,” Ca-A Cancer Journal for Clinicians, vol. 52, no. 3, pp. 23–47, 2002. View at Scopus
  3. H. G. Beger, B. Rau, F. Gansauge, G. Leder, M. Schwarz, and B. Poch, “Pancreatic cancer–low survival rates,” Deutsches Arzteblatt, vol. 105, no. 14, pp. 255–262, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. J. E. Lim, M. W. Chien, and C. C. Earle, “Prognostic factors following curative resection for pancreatic adenocarcinoma: a population-based, linked database analysis of 396 patients,” Annals of Surgery, vol. 237, no. 1, pp. 74–85, 2003. View at Publisher · View at Google Scholar · View at Scopus
  5. J. L. Cameron, T. S. Riall, J. Coleman, and K. A. Belcher, “One thousand consecutive pancreaticoduodenectomies,” Annals of Surgery, vol. 244, no. 1, pp. 10–15, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. G. Schneider, J. T. Siveke, F. Eckel, and R. M. Schmid, “Pancreatic cancer: basic and clinical aspects,” Gastroenterology, vol. 128, no. 6, pp. 1606–1625, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. R. J. Geer, M. F. Brennan, J. Cameron et al., “Prognostic indicators for survival after resection of pancreatic adenocarcinoma,” American Journal of Surgery, vol. 165, no. 1, pp. 68–73, 1993. View at Scopus
  8. S. S. Nitecki, M. G. Sarr, T. V. Colby, and J. A. van Heerden, “Long-term survival after resection for ductal adenocarcinoma of the pancreas: is it really improving?” Annals of Surgery, vol. 221, no. 1, pp. 59–66, 1995. View at Scopus
  9. J. D. Birkmeyer, A. L. Warshaw, S. R. G. Finlayson, M. R. Grove, and A. N. A. Tosteson, “Relationship between hospital volume and late survival after pancreaticoduodenectomy,” Surgery, vol. 126, no. 2, pp. 178–183, 1999. View at Publisher · View at Google Scholar · View at Scopus
  10. M. H. Kalser and S. S. Ellenberg, “Pancreatic cancer. Adjuvant combined radiation and chemotherapy following curative resection,” Archives of Surgery, vol. 120, no. 8, pp. 899–903, 1985. View at Scopus
  11. J. H. Klinkenbijl, J. Jeekel, T. Sahmoud et al., “Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: phase III trial of the EORTC gastrointestinal tract cancer cooperative group,” Annals of Surgery, vol. 230, no. 6, pp. 776–784, 1999. View at Publisher · View at Google Scholar · View at Scopus
  12. J. P. Neoptolemos, D. D. Stocken, H. Friess, et al., “A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer,” The New England Journal of Medicine, vol. 350, no. 12, pp. 1200–1210, 2004.
  13. C. C. Hsu, J. M. Herman, M. M. Corsini et al., “Adjuvant chemoradiation for pancreatic adenocarcinoma: the johns hopkins hospital-mayo clinic collaborative study,” Annals of Surgical Oncology, vol. 17, no. 4, pp. 981–990, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. A. L. Warshaw and C. Fernández-del Castillo, “Pancreatic carcinoma,” The New England Journal of Medicine, vol. 326, no. 7, pp. 455–465, 1992. View at Scopus
  15. P. Sugarbaker, “Observations concerning cancer spread within the peritoneal cavity and concepts supporting an ordered pathophysiology,” in Peritoneal Carcinomatosis: Principles and Practice of Management, P. Sugarbaker, Ed., pp. 79–100, Kluwer Academic, Boston, Mass, USA, 1996.
  16. P. H. Sugarbaker, “Peritonectomy procedures,” Annals of Surgery, vol. 221, no. 1, pp. 29–42, 1995. View at Scopus
  17. P. Jacquet and P. H. Sugarbaker, “Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis,” in Peritoneal Carcinomatosis: Principles and Practice of Management, P. Sugarbaker, Ed., pp. 369–374, Kluwer Academic, Boston, Mass, USA, 1996.
  18. R. L. Dedrick, “Theoretical and experimental bases of intraperitoneal chemotherapy,” Seminars in Oncology, vol. 12, no. 3, supplement 4, pp. 1–6, 1985.
  19. H. Oettle, S. Post, P. Neuhaus et al., “Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial,” Journal of the American Medical Association, vol. 297, no. 3, pp. 267–277, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. K. Ridwelski, F. Meyer, A. Hribaschek, U. Kasper, and H. Lippert, “Intraoperative and early postoperative chemotherapy into the abdominal cavity using gemcitabine may prevent postoperative occurence of peritoneal carcinomatosis,” Journal of Surgical Oncology, vol. 79, no. 1, pp. 10–16, 2002. View at Publisher · View at Google Scholar · View at Scopus
  21. T. C. Gamblin, M. J. Egorin, E. G. Zuhowski et al., “Intraperitoneal gemcitabine pharmacokinetics: a pilot and pharmacokinetic study in patients with advanced adenocarcinoma of the pancreas,” Cancer Chemotherapy and Pharmacology, vol. 62, no. 4, pp. 647–653, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. S. R. Pestieau, O. A. Stuart, D. Chang, P. Jacquet, and P. H. Sugarbaker, “Pharmacokinetics of intraperitoneal gemcitabine in a rat model,” Tumori, vol. 84, no. 6, pp. 706–711, 1998. View at Scopus
  23. P. H. Sugarbaker, J. T. Mora, P. Carmignani, O. A. Stuart, and D. Yoo, “Update on chemotherapeutic agents utilized for perioperative intraperitoneal chemotherapy,” Oncologist, vol. 10, no. 2, pp. 112–122, 2005. View at Publisher · View at Google Scholar · View at Scopus
  24. P. Sabbatini, C. Aghajanian, M. Leitao et al., “Intraperitoneal cisplatin with intraperitoneal gemcitabine in patients with epithelial ovarian cancer: results of a phase I/II trial,” Clinical Cancer Research, vol. 10, no. 9, pp. 2962–2967, 2004. View at Publisher · View at Google Scholar · View at Scopus
  25. J. L. Speyer, P. H. Sugarbaker, J. M. Collins, R. L. Dedrick, R. W. Klecker Jr., and C. E. Myers, “Portal levels and hepatic clearance of 5-fluorouracil after intraperitoneal administration in humans,” Cancer Research, vol. 41, pp. 1916–1922, 1981.